Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:avermectin |
| gptkbp:CASNumber |
65195-56-4
|
| gptkbp:drugClass |
antineoplastic agent
|
| gptkbp:has_ATCvet_code |
QP54AA01
|
| gptkbp:has_parent_compound |
gptkb:avermectin_B
|
| gptkbp:hasMolecularFormula |
C48H72O14
|
| https://www.w3.org/2000/01/rdf-schema#label |
avermectin B2a
|
| gptkbp:isomerOf |
gptkb:avermectin_B1a
|
| gptkbp:IUPACName |
(10E,14E,16E,22Z)-6,8,19,25-tetrahydroxy-5,11,13,22-tetramethyl-23-(methoxycarbonyl)-3,7,19-trioxapentacyclo[19.3.1.1^{2,6}.1^{9,13}.0^{15,20}]hexacosa-1(25),2,4,9(26),10,12,14,16,18,20,22-undecaen-24-yl 2,6-dideoxy-4-O-methyl-3-O-methylamino-α-L-arabino-hexopyranoside
|
| gptkbp:partOf |
avermectin mixture
|
| gptkbp:bfsParent |
gptkb:avermectin
|
| gptkbp:bfsLayer |
6
|